Novo CEO pressed by Senate to chop costs of weight problems, diabetic issues medication CEO Lars Fruergaard Jørgensen explained to lawmakers the corporate would contemplate new talks with insurers regarding the list rates of Wegovy and copyright should they pledge to help keep the medicines on their own formularies. Insurers https://kethek.com/